Modern Treatment Options for CLL

Dr. Anthony Mato explains novel therapeutics in Chronic Lymphocytic Leukemia (CLL). Dr. Mato reviews different trials and provides effective frontline therapy options.

Back to Symposium Page »


March 20, 2021

Created by

Scripps CME Connection

Related Presenters

Anthony Mato, MD, MSCE

Anthony Mato, MD, MSCE

Director, CLL Program
Hematologic Oncologist
Memorial Sloan Kettering Cancer Center

Dr. Anthony Mato is an Associate Member at Memorial Sloan Kettering Cancer Center and Director of the Chronic Lymphocytic Leukemia (CLL) Program at MSKCC. He received his medical degree from the State University of New York (SUNY) at Buffalo, ...

View full profile